GLPG Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.06% compare to its pairs and should correct upwards.

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need...

Stats
Today's Volume	215 510
Average Volume	121 404
Market Cap	1.63B
EPS	$1.370 ( Q1 \| 2024-05-03 )
Next earnings date	( $-0.0200 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	49.56 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0140 (0.06%)

AADI -10.43%

ABCL 2.78%

ABCM 0.04%

ABEO 1.19%

ABIO 6.39%

ABOS 2.54%

ABSI 0.98%

ABUS -0.32%

ABVX 3.69%

ACAD -0.73%

ACER -17.95%

ACET -9.70%

ACGN 1.29%

ACHL 0.62%

ACHV 1.29%

ACIU 0.50%

ACLX 1.98%

ACRV 0.69%

ACST -2.67%

ACXP -2.60%

ADAG 6.66%

ADAP -0.60%

ADGI 0.87%

ADIL 1.77%

ADMA 2.10%

ADPT 4.62%

ADTX -2.84%

ADVM -1.72%

ADXN -3.06%

AEON -0.94%

AEZS -2.64%

AFMD 0.00%

AGEN 18.63%

AGIO -1.12%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 3.11%

AKRO 0.26%

AKTX 0.75%

AKUS 0.00%

ALBO 0.00%

ALDX -2.65%

ALEC 0.00%

ALGS -7.51%

ALKS -0.78%

ALLK -5.66%

ALLO -4.51%

ALLR 3.85%

ALNA 3.16%

ALNY -1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -4.48%

ALT 4.15%

ALVR -7.27%

ALXN 0.00%

ALXO 3.34%

ALZN -0.65%

AMRN -1.84%

AMTI -3.13%

ANAB 1.05%

ANEB 3.80%

ANGN 0.00%

ANIX -7.14%

ANL -6.05%

ANNX 1.66%

ANPC -3.15%

APGE -1.50%

APGN 8.48%

APGNW 30.65%

APLM 1.30%

APLS -7.61%

APLT 1.52%

APM -5.26%

APOP 0.38%

APRE -0.49%

APTO 1.20%

APTX 3.17%

APVO -40.57%

ARAV -13.39%

ARCT -0.41%

ARDS -17.87%

ARDX 14.00%

ARGX -3.35%

ARNA 0.00%

ARPO -0.90%

ARQT -1.27%

ARTL 3.08%

ARTLW 0.00%

ARVN 2.98%

ARWR 1.17%

ASLN 4.90%

ASMB -6.03%

ASND 0.72%

ATAI 0.76%

ATHA 0.38%

ATHE 0.56%

ATHX -33.50%

ATNF 9.27%

ATOS 4.39%

ATRA 2.91%

ATXI -2.23%

ATXS -1.30%

AUPH 1.60%

AURA 3.85%

AUTL 4.50%

AVBP 6.61%

AVEO 0.00%

AVIR -2.07%

AVRO -1.41%

AVTE -0.60%

AVTX -5.53%

AVXL -1.63%

AXLA 0.00%

AXSM 0.51%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB -6.80%

BCDA -0.34%

BCDAW 0.00%

BCEL 0.00%

BCLI -6.08%

BCRX 1.15%

BCTX 9.62%

BCTXW 1.47%

BCYC -0.15%

BDRX 2.98%

BDTX -0.85%

BEAM -2.29%

BFRA -2.91%

BGNE -2.00%

BIOR 2.37%

BIVI -10.22%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.37%

BLTE -1.76%

BLU 0.03%

BLUE 3.74%

BMEA -0.66%

BMRN -1.40%

BNOX 3.51%

BNTC -0.71%

BNTX -0.02%

BOLD -14.76%

BOLT 0.32%

BPMC -0.68%

BPTH 2.56%

BPTS -13.47%

BRNS 1.45%

BRTX 10.93%

BTAI 0.79%

BTTX 30.91%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -2.44%

CABA 1.91%

CADL 5.26%

CALA 0.00%

CALC 25.71%

CALT 0.72%

CAPR 2.80%

CARA -15.27%

CARM 18.75%

CASI 12.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 3.79%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO 0.37%

CDIOW 21.56%

CDMO 1.85%

CDMOP 0.04%

CDT 3.92%

CDTTW -12.92%

CDTX 6.70%

CDXC 3.02%

CDXS 2.99%

CELC 0.68%

CELU 11.79%

CELUW 0.00%

CERC -1.68%

CERE 0.96%

CERO -1.77%

CEROW 43.57%

CFRX -27.95%

CGEM 2.05%

CGEN -4.55%

CGON 4.36%

CGTX -0.60%

CHMA -6.00%

CHRS 1.76%

CINC 0.00%

CING -45.21%

CINGW 4.85%

CKPT 4.37%

CLBS -16.75%

CLDX -1.80%

CLGN -0.60%

CLLS 0.54%

CLNN -3.47%

CLNNW 3.32%

CLRB 7.30%

CLSD 1.56%

CLSN -0.68%

CLVS 0.00%

CMMB -4.26%

CMND 25.37%

CMPI 0.00%

CMPX -16.67%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.47%

CNCE 0.00%

CNSP -4.82%

CNST 0.00%

CNTA 0.56%

CNTB 18.75%

CNTX -0.25%

COCP -8.63%

COEPW 0.00%

COGT -0.12%

CORT 1.34%

COYA -0.49%

CPRX 2.99%

CRBP 3.12%

CRBU -2.38%

CRDF -4.72%

CRGX 4.99%

CRIS -7.38%

CRNX 3.04%

CRSP -2.47%

CRTX 2.63%

CRVO -0.29%

CRVS -2.67%

CSBR 0.39%

CTCX 9.02%

CTIC 0.06%

CTMX -3.17%

CTNM -6.08%

CTXR -8.54%

CUE -11.43%

CVAC 1.19%

CVKD 1.82%

CWBR 0.00%

CYAD -12.96%

CYCC -4.71%

CYCCP -11.68%

CYCN 5.99%

CYT -2.27%

CYTK 0.74%

CYTO 0.00%

DARE -8.79%

DAWN -0.36%

DBTX -0.81%

DBVT -5.53%

DFFN 10.28%

DICE 0.06%

DMAC -3.28%

DNLI 1.09%

DNTH 3.85%

DOMH -1.58%

DRMA 4.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 23.41%

DRTSW -8.84%

DRUG 2.32%

DSGN 0.00%

DTIL 3.29%

DYAI -6.33%

EARS -1.77%

EDIT -1.48%

EDSA -2.51%

EFTR -6.42%

EFTRW 0.00%

EIGR -9.21%

ELAB -1.48%

ELDN 1.54%

ELEV 7.57%

ELOX 12.20%

ELTX -40.35%

ELVN -0.34%

ELYM -5.58%

ENGN 5.13%

ENGNW -0.83%

ENLV -4.70%

ENOB 1.79%

ENSC -2.78%

ENTA 2.37%

ENTO 2.51%

ENTX -5.64%

ENVB 0.71%

EPIX 1.54%

EPRX 0.78%

EPZM 0.00%

EQ 3.77%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.16%

ERNA 5.17%

ERYP 1.30%

ESLA 12.90%

ESLAW 0.00%

ETNB 6.23%

ETON -0.90%

ETTX 0.00%

EVAX 1.05%

EVGN -5.74%

EVLO 0.00%

EWTX 2.91%

EXAI -2.30%

EXEL -0.27%

EYEG -0.50%

EYEN -14.16%

EYPT -0.57%

FATE 0.46%

FBIO 1.79%

FBIOP 1.02%

FBLG 7.08%

FBRX -2.01%

FDMT 0.29%

FENC -0.65%

FGEN -13.37%

FHTX 0.17%

FIXX 0.77%

FMTX 0.00%

FNCH 13.22%

FOLD 0.10%

FREQ 4.76%

FRLN 0.15%

FRTX 5.56%

FSTX 0.00%

FTRE 2.01%

FULC -1.27%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 2.73%

GANX 2.40%

GBIO -1.05%

GBT 0.01%

GDTC 5.05%

GERN -4.50%

GHRS -2.75%

GLMD 2.46%

GLPG -1.43%

GLSI 2.25%

GLTO -5.16%

GLUE 10.65%

GLYC -11.22%

GMAB -1.76%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -6.48%

GNLX -11.36%

GNPX -3.33%

GNTA -0.32%

GOSS -5.38%

GOVX -10.28%

GOVXW -20.59%

GPCR 0.33%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -12.42%

GRTX 1.33%

GTHX 1.33%

GUTS -3.61%

GXGXW 41.67%

GYRE 20.63%

HALO 1.41%

HARP 0.09%

HCWB 1.06%

HEPA -5.55%

HGEN -84.62%

HILS 5.66%

HLVX 8.15%

HOOK -8.97%

HOTH -0.79%

HOWL -2.79%

HRMY -4.16%

HRTX 2.64%

HSTO 0.00%

HUMA 2.13%

HUMAW -1.42%

IBRX -3.36%

ICCC 11.24%

ICPT 0.21%

ICU 10.16%

ICUCW 12.50%

ICVX -0.91%

IDRA -23.04%

IDYA 2.15%

IFRX 4.19%

IGMS 3.93%

IKNA -5.71%

IKT -12.32%

IMAB -1.18%

IMCR 0.33%

IMGN 0.02%

IMGO 0.00%

IMMP 7.49%

IMMX -7.04%

IMNM 1.09%

IMNN 0.87%

IMPL -27.27%

IMRA 15.96%

IMRN -3.97%

IMRX -10.49%

IMTX -1.44%

IMTXW 2.21%

IMUX 8.82%

IMV 0.00%

IMVT 1.54%

INAB -5.87%

INBX 0.78%

INCY -1.19%

INDP -7.02%

INFI -52.38%

INKT 2.06%

INM 0.19%

INMB 1.50%

INO 4.12%

INSM 0.07%

INTS 0.20%

INVA 1.23%

INZY -1.33%

IOBT -0.85%

IONS 0.91%

IOVA 0.12%

IPA 1.23%

IPHA -1.52%

IPSC 0.79%

IRON 1.62%

ISEE 0.38%

ITOS -4.26%

ITRM -4.58%

IVA -0.33%

IVVD -8.33%

JAGX -1.11%

JANX 3.84%

JAZZ -0.35%

JNCE 0.00%

JSPR 3.13%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA -5.43%

KALV -2.24%

KDNY 0.22%

KMPH -0.34%

KNSA 0.43%

KNTE -0.38%

KOD -3.29%

KPRX 1.20%

KPTI -10.84%

KRBP 6.83%

KRON 3.33%

KROS 1.40%

KRRO 1.20%

KRTX 0.03%

KRYS 0.42%

KTRA -3.60%

KTTA 1.62%

KTTAW 0.92%

KURA 0.44%

KYMR -1.22%

KYTX 1.90%

KZIA 2.65%

KZR -5.41%

LABP 0.57%

LBPH 20.19%

LBPS 0.00%

LBPSW 14.81%

LEGN -0.83%

LENZ -2.92%

LEXX 5.70%

LEXXW -5.15%

LGND 2.34%

LGNDV 0.00%

LGVN -4.17%

LIAN -8.28%

LIFE 2.70%

LIPO -3.43%

LIXT -2.47%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -2.06%

LPCN 6.32%

LPTX 10.73%

LQDA -3.07%

LRMR -1.36%

LSTA -0.57%

LTRN 2.86%

LUMO 2.20%

LVTX -3.74%

LXEO 7.94%

LXRX -3.45%

LYEL 5.07%

LYRA 5.93%

MACK 0.10%

MBIO 1.59%

MBRX -3.83%

MCRB -7.80%

MDGL -1.93%

MDNA -13.16%

MDWD 4.30%

MDXG 2.51%

MEIP -1.36%

MESO -0.58%

MGNX 3.16%

MGTA -7.74%

MGTX -0.47%

MGX 8.22%

MIRM 3.26%

MIRO 0.59%

MIST 2.33%

MITO 0.00%

MLEC 1.85%

MLECW -28.57%

MLND -5.36%

MLTX 5.47%

MLYS 1.74%

MNKD -1.32%

MNMD -0.55%

MNOV 0.00%

MNPR -1.67%

MOLN 4.33%

MOR 0.17%

MORF 0.18%

MREO 3.45%

MRKR 12.42%

MRNA -2.01%

MRNS -4.88%

MRSN 0.75%

MRTX -0.17%

MRUS -1.71%

MRVI 1.13%

MTCR -1.29%

MTEM 3.60%

MTP -18.50%

MURA 2.28%

MYMD -1.08%

NAMS -1.69%

NAMSW -3.11%

NAUT 2.63%

NBRV 0.71%

NBSE -1.56%

NBTX -10.71%

NCNA -4.49%

NERV 4.59%

NEXI 0.00%

NGM -1.28%

NGNE 4.51%

NKGN 2.42%

NKGNW -12.00%

NKTR 8.77%

NKTX 0.85%

NLSP -9.63%

NLSPW 7.48%

NMRA 6.85%

NMTR -42.97%

NOVN -24.84%

NRBO 0.83%

NRIX 0.63%

NRSN 9.80%

NRSNW 21.18%

NRXP -6.87%

NRXPW -16.53%

NRXS 4.51%

NTBL -6.32%

NTEC -12.45%

NTHI 0.00%

NTLA -3.49%

NTRBW 74.65%

NUVL -1.44%

NVAX -1.33%

NVCT 0.96%

NVIV -34.28%

NXTC -3.05%

NYMX -0.05%

OABI -0.53%

OABIW 6.37%

OBIO 2.77%

OBSV 0.00%

OCEA -11.59%

OCGN 8.39%

OCS 1.44%

OCUL 1.18%

OCUP 0.66%

ODT -4.27%

OKYO 0.85%

OLMA -3.48%

OMER 2.78%

OMGA -7.59%

ONCO -18.40%

ONCR -3.08%

ONCS 31.87%

ONCT -1.17%

ONCY -1.98%

ONTX -0.47%

ONVO -0.41%

OPNT 0.00%

OPT 3.21%

ORGS -5.36%

ORIC 2.32%

ORMP -4.10%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.73%

OVID 5.89%

OYST 0.00%

PALI -1.53%

PASG -14.04%

PBLA 11.11%

PBM -8.81%

PBYI 0.93%

PCSA 8.21%

PCVX -4.14%

PDSB -2.66%

PEPG -3.04%

PGEN 4.64%

PHAR 3.47%

PHAS 0.00%

PHAT -0.96%

PHIO 1.75%

PHIOW 36.47%

PHVS 4.39%

PHXM -5.20%

PIRS 5.83%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.84%

PLUR 7.04%

PMN -1.96%

PMVP -2.41%

PNT 0.16%

PPBT -6.42%

PRAX 4.02%

PRDS 0.93%

PRLD 3.25%

PROG -3.47%

PROK 1.65%

PRQR 0.61%

PRTA 0.54%

PRTC 4.56%

PRTG -6.11%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.34%

PSTX 7.35%

PTCT -11.77%

PTE -0.82%

PTGX 8.69%

PTIXW -47.77%

PULM 0.52%

PXMD -9.45%

PYPD 3.12%

PYXS 3.12%

QLGN -3.31%

QNCX 4.87%

QNRX -2.85%

QSI 11.70%

QSIAW 4.08%

QTTB 17.70%

QURE -1.32%

RAIN -1.63%

RANI -3.55%

RAPT 5.54%

RARE -0.77%

RCKT 0.47%

REGN 0.02%

RENB 16.67%

REPL 5.63%

RETA 0.02%

REUN -0.89%

REVB 2.69%

REVBU 3.46%

REVBW 19.05%

RGLS -11.85%

RGNX 0.60%

RIGL -13.75%

RLAY 3.49%

RLMD 0.33%

RLYB -9.46%

RNA 0.76%

RNAC -5.29%

RNAZ -0.50%

RNXT -2.59%

ROIV 0.00%

ROIVW 4.56%

RPHM -6.21%

RPRX -1.12%

RPTX -2.37%

RUBY 2.70%

RVLP -32.05%

RVMD 0.73%

RVMDW 45.86%

RVNC -0.39%

RVPH 0.00%

RVPHW 1.89%

RXDX 0.09%

RXRX -0.99%

RYTM 2.32%

RYZB 0.02%

RZLT 7.23%

SABS 6.16%

SABSW 35.43%

SAGE 1.59%

SANA 1.11%

SAVA -34.83%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -2.80%

SCPH -0.46%

SCPS 0.00%

SEEL -2.10%

SEER -4.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -10.11%

SGMT -16.79%

SGTX -2.56%

SIOX 22.63%

SLDB -1.22%

SLGL 3.37%

SLN 0.00%

SLNO -2.28%

SLRX -2.86%

SLS 4.39%

SMMT -0.89%

SNDX 1.03%

SNGX -7.19%

SNPX 0.99%

SONN -1.41%

SPPI -0.49%

SPRB -2.72%

SPRC -5.99%

SPRO -2.99%

SRNE 5.26%

SRPT 0.03%

SRRA 0.00%

SRRK -0.36%

SRZN 10.16%

STAB 0.00%

STOK 1.50%

STRO 0.34%

STSA 0.00%

STTK 2.93%

SURF -0.93%

SVRA 5.77%

SWTX 0.37%

SYBX -1.96%

SYRS -9.95%

TALS -0.73%

TARA -4.15%

TARS 7.99%

TBPH 1.80%

TCBP -1.31%

TCDA 0.00%

TCON -1.38%

TCRR 0.00%

TCRT -2.92%

TCRX -6.25%

TECH -0.24%

TENX 1.17%

TERN -4.22%

TFFP 3.11%

TGTX -0.89%

THRX 0.12%

TIL -1.06%

TLC 0.00%

TLSA 4.43%

TNGX 0.47%

TNXP 1.07%

TNYA 5.44%

TPST 0.92%

TRDA 0.56%

TRVI 1.36%

TRVN 1.40%

TSHA 3.46%

TSVT 2.39%

TTNP 0.91%

TVTX -0.72%

TYRA 3.50%

UBX -2.17%

UNCY 23.70%

URGN -1.12%

UTHR 0.51%

VACC 11.36%

VALN -5.14%

VAXX -0.24%

VBIV 1.54%

VBLT -8.77%

VCEL -2.20%

VCNX 2.69%

VCYT -1.46%

VERA 4.39%

VERU 5.16%

VERV 2.52%

VIGL -10.71%

VINC 9.46%

VIR 0.34%

VIRI -8.20%

VIRX -5.93%

VKTX 4.41%

VLON -13.04%

VNDA -2.75%

VOR -12.28%

VRCA 0.97%

VRDN 1.80%

VRNA -6.35%

VRPX -0.52%

VRTX -0.80%

VSTM 2.76%

VTGN 0.00%

VTVT -0.34%

VTYX -3.35%

VXRT 0.20%

VYGR 0.64%

VYNE 0.00%

VYNT 7.78%

WINT -3.60%

WVE 0.00%

XBIO 1.50%

XBIT 11.50%

XCUR 5.89%

XENE 4.22%

XERS -0.44%

XFOR -13.45%

XLO 0.80%

XLRN 0.00%

XNCR -1.41%

XOMA 3.45%

XOMAO 0.24%

XOMAP 0.08%

XRTX 0.00%

YMAB -2.03%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.08%

ZNTL -2.62%

ZSAN 0.00%

Correlation (AI algo v.1.1b): Undervalued: 0.06% $24.80 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.43 (neutral)

Short: -0.40 (neutral)

Signal:(40.73) Neutral

Galapagos NV Correlation

10 Most Positive Correlations
SIRI	0.971
FXNC	0.958
APTO	0.957
BPTH	0.956
PACB	0.955
HTLD	0.955
AKTX	0.954
PRTS	0.954
NLSP	0.954
ARKO	0.953

10 Most Negative Correlations
SWAV	-0.97
PPC	-0.968
PNTG	-0.967
RZLT	-0.955
ENTX	-0.949
FANG	-0.949
TCOM	-0.947
APP	-0.946
ARYD	-0.945
FRLA	-0.944

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Galapagos NV Correlation - Currency/Commodity

0.86
( strong )

0.78
( moderate )

0.00
( neutral )

0.73
( moderate )

-0.29
( neutral )

0.05
( neutral )

Galapagos NV Financials

Annual	2023
Revenue:	$239.72M
Gross Profit:	$239.70M (99.99 %)
EPS:	$3.21

FY	2023
Revenue:	$239.72M
Gross Profit:	$239.70M (99.99 %)
EPS:	$3.21

FY	2022
Revenue:	$505.28M
Gross Profit:	$493.20M (97.61 %)
EPS:	$-3.32

FY	2021
Revenue:	$484.85M
Gross Profit:	$483.22M (99.66 %)
EPS:	$-1.580

Financial Reports:

No articles found.

Galapagos NV Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Galapagos NV

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.